Latest AAM Report Calculates $467bn In Annual Off-Patent Savings

Savings From Biosimilars Alone Increased To $20.2bn In 2024

 
• By Dave Wallace
  
Using generics and biosimilars saved the US around $467bn in 2024 (Shutterstock)

More from Generics

More from Products